Mark Mcdade
Director at Tourmaline Bio, Inc. (TRML)
Mark Mcdade has filed 11 insider reports with the SEC since April 2022, as director at Tourmaline Bio, Inc. (TRML), insider at Icosavax, Inc. (ICVX) and director at Tourmaline Bio, Inc. (TALS). Mark Mcdade made no open-market purchases or sales in the last 12 months. The latest filing, on October 28, 2025, reports sale back to the company and tender of shares in a change of control at Tourmaline Bio, Inc. (TRML).
- Filings
- 11
- Companies
- 3
- Bought on market
- $3.55M
- Sold on market
- None
Companies where Mark Mcdade is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 0 | Oct 28, 2025 | |||||
| Insider | 0 | $300K | $7.10 | Feb 21, 2024 | |||
| Director | 518 | $3.25M | $32.50 | Jan 31, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Oct 28, 2025TRMLDirector Mcdade Mark closing all direct ownership in the companyForm 4Sale back to the companyTender of shares in a change of control
- Jun 4, 2025TRMLSEC Form 4 filed by Director Mcdade MarkForm 4Grant or award
- Jun 5, 2024TRMLSEC Form 4 filed by Mcdade MarkForm 4Grant or award
- Feb 19, 2024ICVXMcdade Mark closing all direct ownership in the companyForm 4Sale back to the companyTender of shares in a change of control
- Jan 29, 2024+$3.25MTALSMcdade Mark bought $3,250,000 worth of shares (100,000 units at $32.50)Form 4Open-market purchase
- Oct 23, 2023TALSMcdade Mark was granted 348,949 sharesForm 4Grant or awardSale back to the company
- Jun 13, 2023TALSSEC Form 4 filed by Mcdade MarkForm 4Grant or award
- Jun 6, 2023ICVXSEC Form 4 filed by Mcdade MarkForm 4Grant or award
- Jun 10, 2022ICVXSEC Form 4: Mcdade Mark was granted 5,543 shares, increasing direct ownership by 11% to 55,786 unitsForm 4Grant or award
- Jun 9, 2022TALSSEC Form 4 filed by Mcdade MarkForm 4Grant or award
- Apr 1, 2022+$300KICVXSEC Form 4: Mcdade Mark bought $299,798 worth of shares (42,225 units at $7.10), increasing direct ownership by 527% to 50,243 unitsForm 4Open-market purchase
Also sits on boards with
Officers and directors who share two or more companies with Mark Mcdade.
- Clay B Siegall2 shared: TRML, TALS
- Sapna Srivastava2 shared: TRML, TALS
- Parvinder Thiara2 shared: TRML, TALS
- Caley Castelein2 shared: TRML, TALS
- Aaron Kantoff2 shared: TRML, TALS
- Sandeep Chidambar Kulkarni2 shared: TRML, TALS
- Kevin Bruce Johnson2 shared: TRML, TALS
- W Bradford Middlekauff2 shared: TRML, TALS
- Ryan F. Robinson2 shared: TRML, TALS
- Susan Dana Jones2 shared: TRML, TALS
Compare Mark Mcdade with
- Mark Mcdade vs Clay B Siegall2 shared
- Mark Mcdade vs Sapna Srivastava2 shared
- Mark Mcdade vs Parvinder Thiara2 shared
- Mark Mcdade vs Caley Castelein2 shared
- Mark Mcdade vs Aaron Kantoff2 shared
- Mark Mcdade vs Sandeep Chidambar Kulkarni2 shared
Other insiders at the same companies
Questions about Mark Mcdade
- What is Mark Mcdade's role at Tourmaline Bio, Inc.?
- Mark Mcdade reports to the SEC as director at Tourmaline Bio, Inc. (TRML), according to the latest filing on October 28, 2025. Mark Mcdade has also filed as insider at Icosavax, Inc. (ICVX) and director at Tourmaline Bio, Inc. (TALS).
- How many shares does Mark Mcdade own?
- After the latest filing that states it, Mark Mcdade directly owned 518 shares of Tourmaline Bio, Inc. (TALS). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Mark Mcdade bought or sold stock recently?
- The most recent open-market purchase was on January 29, 2024: bought 100,000 shares of Tourmaline Bio, Inc. (TALS) for $3.25M at an average of $32.50.
- How do I get alerts when Mark Mcdade files?
- Follow Mark Mcdade on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Mark Mcdade (SEC CIK 0001242126). Totals count each trade once, skipping amendments whose original is on file, from Apr 5, 2022 on. View on SEC EDGAR